Percutaneous Closure of Gerbode Defect

Kluck, Margaret; Secheresiu, Paul; Klein, Jordan A.; Kluck, Bryan; Makowski, Daniel; Vyas, Apurva

doi:10.1016/s0735-1097(21)04344-8

Journal of the American College of Cardiology

2021

DOI: 10.1016/s0735-1097(21)04344-8

|View full text |Cite

Percutaneous Closure of Gerbode Defect

Margaret Kluck¹,

Paul Secheresiu²,

Jordan A. Klein³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A 12/10 ADO I device was successfully released within the defect after confirming the absence of impingement of the aortic valve prosthesis or the TV leaflets and no relevant residual shunt ( Figure 1G–J , see Supplementary material online , videos S7–S10 ). 2 The procedure was uneventful.…”

mentioning

confidence: 98%

Transcatheter closure of residual Gerbode defect after aortic valve replacement surgery

Slim

Mekki

Ouannes

et al. 2022

European Heart Journal - Case Reports

View full text Add to dashboard Cite

A 42-year-old man with a history of surgically repaired coarctation of the aorta presented with a refractory right heart failure. Echocardiography revealed a calcified bicuspid aortic valve both regurgitant and stenotic and a defect within the membranous septum with left to right shunt from the left ventricle (LV) to the right atrium. The patient was referred to surgery for an aortic valve replacement and closure with patch repair of the Gerbode type defect. Post-operative course was complicated by refractory heart failure with a persistent left to right shunt through the defect due to loose sutures. Taking into account the high surgical risk, percutaneous closure of the defect was decided. An Amplatzer Duct Occluder (St Jude Medical, USA) I device was successfully released within the defect. The patient was completely asymptomatic on follow-up.

show abstract

mentioning

confidence: 98%

Transcatheter closure of residual Gerbode defect after aortic valve replacement surgery

Slim

Mekki

Ouannes

et al. 2022

European Heart Journal - Case Reports

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Percutaneous Closure of Gerbode Defect

Cited by 1 publication

References 0 publications

Transcatheter closure of residual Gerbode defect after aortic valve replacement surgery

Transcatheter closure of residual Gerbode defect after aortic valve replacement surgery

Contact Info

Product

Resources

About